Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangnan Liang

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Transplantation Proceedings|January 27, 2023
Risk Factors Related to Early Biliary Complications After Liver Transplantation: a Single-Center AnalysisLida Suo, Xiangnan Liang, Weibin Zhang, et al.
BMC Geriatrics|December 3, 2025
Sarcopenia is associated with early postoperative cognitive decline in older adults following hip fracture surgery: a prospective cohort studyTao Jiang, Pingjuan Wang, Jianxiao Wu, et al.
Human & Experimental Toxicology|October 23, 2024
Downregulation of miR-138-5p alleviates propofol-induced neurotoxicity and autophagy by regulating SIRT1Xiaolong Zhang, Yiqiao Wang, Feng Xu, et al.
Biochemical Genetics|June 4, 2024
Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular CarcinomaWeibin Zhang, Jia Dong, Yunfei Wu, et al.
Future Oncology (London, England)|December 20, 2024
METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patientsJialing Zhao, Ruiqi Sun, Liang Zhi, et al.
Journal of Cancer Research and Clinical Oncology|May 1, 2025
RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP/PKA/CREB signaling pathwayXiangnan Liang, Bin Xu, Qiuxiang Wang, et al.
The International Journal of Biological Markers|November 13, 2023
Potential prognostic biomarkers of hepatocellular carcinoma based on 4D label-free quantitative proteomics analysis pilot investigationLida Suo, Xiangnan Liang, Weibin Zhang, et al.
Zhongguo Yi Liao Qi Xie Za Zhi = Chinese Journal of Medical Instrumentation|February 17, 2019
[Three-dimensional Medical Electronic Laparoscope System]Lun Cao, Haoyang Mao, Xiangnan Liang, et al.
Frontiers in Oncology|January 22, 2024
The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapyYilin Song, Quanlin Song, Daosheng Hu, et al.
Hereditas|July 31, 2025
EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell linesBin Xu, Xiangnan Liang, Wuguang Liu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Transplantation Proceedings|January 27, 2023
Risk Factors Related to Early Biliary Complications After Liver Transplantation: a Single-Center AnalysisLida Suo, Xiangnan Liang, Weibin Zhang, et al.
BMC Geriatrics|December 3, 2025
Sarcopenia is associated with early postoperative cognitive decline in older adults following hip fracture surgery: a prospective cohort studyTao Jiang, Pingjuan Wang, Jianxiao Wu, et al.
Human & Experimental Toxicology|October 23, 2024
Downregulation of miR-138-5p alleviates propofol-induced neurotoxicity and autophagy by regulating SIRT1Xiaolong Zhang, Yiqiao Wang, Feng Xu, et al.
Biochemical Genetics|June 4, 2024
Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular CarcinomaWeibin Zhang, Jia Dong, Yunfei Wu, et al.
Future Oncology (London, England)|December 20, 2024
METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patientsJialing Zhao, Ruiqi Sun, Liang Zhi, et al.
Journal of Cancer Research and Clinical Oncology|May 1, 2025
RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP/PKA/CREB signaling pathwayXiangnan Liang, Bin Xu, Qiuxiang Wang, et al.
The International Journal of Biological Markers|November 13, 2023
Potential prognostic biomarkers of hepatocellular carcinoma based on 4D label-free quantitative proteomics analysis pilot investigationLida Suo, Xiangnan Liang, Weibin Zhang, et al.
Zhongguo Yi Liao Qi Xie Za Zhi = Chinese Journal of Medical Instrumentation|February 17, 2019
[Three-dimensional Medical Electronic Laparoscope System]Lun Cao, Haoyang Mao, Xiangnan Liang, et al.
Frontiers in Oncology|January 22, 2024
The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapyYilin Song, Quanlin Song, Daosheng Hu, et al.
Hereditas|July 31, 2025
EPHX1 enhances drug resistance to regorafenib by activating the JAK/STAT signaling pathway in hepatocellular carcinoma cell linesBin Xu, Xiangnan Liang, Wuguang Liu, et al.
Pageof 2